Announcements Trials
Browse Landscape

Status

Completed 6Recruiting 2

Sponsor Class

OTHER 4INDUSTRY 4

Study Type

Interventional 229Observational 8Expanded_access 1

Sponsor

Cancer Type

Genitourinary 7Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 7Liver Neoplasms 1

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 446Surgical Procedures, Operative 164Observation 152Drug Therapy 142Radiotherapy 141Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 78Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 66Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 61Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 46

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Observational × cabozantinib × Clear all
NCT04416646 2026-04-13

ZEBRA

Istituto Oncologico Veneto IRCCS

Completed
100 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT05100082 2025-12-30

Survey of Cabozantinib Tablets Used To Treat People With Hepatocellular Carcinoma

Takeda

Completed
263 enrolled
Gastrointestinal

Liver Neoplasms

NCT05287464 2025-11-26

International Multicentric Study ARON-1

Hospital of Macerata

Recruiting
1,220 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT04804813 2025-04-11

Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma

Takeda

Completed
388 enrolled 20 charts
Genitourinary

Carcinoma, Renal Cell

NCT06548867 2024-08-12

CABOGEN

Gruppo Oncologico Italiano di Ricerca Clinica

Recruiting
80 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT04510688 2022-10-26

SRWEC

Spanish Oncology Genito-Urinary Group

Completed
275 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT04353765 2021-11-17

US NIS Cabo

Ipsen

Completed
247 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT04637204 2021-02-01

Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in England

Ipsen

Completed
1,540 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡